|
|
|
|
|
by 0cf8612b2e1e
245 days ago
|
|
I was a bench scientist (proteomics) in pharma for over a decade. There is plenty of sweat and blood going into the pipeline, but a company is ultimately defined by the strength of its (patent) portfolio. Which is why a patent cliff drives their valuations. |
|